Citigroup’s NewAge, Inc. Common Stock (Delaware) NBEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-121,400
Closed -$319K 7728
2020
Q4
$319K Sell
121,400
-4,400
-3% -$12K ﹤0.01% 4606
2020
Q3
$218K Buy
125,800
+9,800
+8% +$19.1K ﹤0.01% 4550
2020
Q2
$177K Buy
116,000
+900
+0.8% +$1.34K ﹤0.01% 5112
2020
Q1
$160K Sell
115,100
-24,900
-18% -$44.8K ﹤0.01% 4926
2019
Q4
$255K Buy
140,000
+81,900
+141% +$194K ﹤0.01% 4981
2019
Q3
$160K Buy
58,100
+37,600
+183% +$133K ﹤0.01% 5321
2019
Q2
$96K Buy
+20,500
New +$105K ﹤0.01% 5920

Other funds holding NBEV

Citigroup's NBEV Position: Q3 2022 in Review

Citigroup sold out of NewAge, Inc. Common Stock (Delaware) (NBEV) in Q3 2022, closing a stake of 10,267 shares — an estimated $2K sold.

Citigroup first reported a position in NBEV in Q1 2019 and held it in 14 quarters. The position peaked at $399K in Q1 2019. 12 funds tracked by Wall St. Rank hold NBEV as of Q3 2022.

  • Citigroup reported no remaining NewAge, Inc. Common Stock (Delaware) position as of Q3 2022 after selling out during the quarter.
  • Citigroup sold 10,267 NewAge, Inc. Common Stock (Delaware) shares in Q3 2022, an estimated $2K.
  • Citigroup first reported a position in NewAge, Inc. Common Stock (Delaware) in Q1 2019 and held it in 14 quarters.
  • Citigroup's NewAge, Inc. Common Stock (Delaware) position peaked at $399K in Q1 2019.
  • 12 funds tracked by Wall St. Rank held NewAge, Inc. Common Stock (Delaware) as of Q3 2022.

Based on Citigroup's 13F filing for Q3 2022, filed 10 Nov 2022.